Infectious Diseases
Conference Coverage
Injecting long-acting antiretrovirals into clinic care
In the peer staff program, workers are trained in a 4-month medical residency–style program that shows them how to test for HIV, inject long-...
Conference Coverage
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
“This [finding] provides a powerful opportunity to help destigmatize HIV, promote the benefits of adhering to antiretroviral therapy, and support...
Latest News
CDC offers guidance on RSV vaccines for adults
Rather than targeting all adults 60 and over, the decision calls for consideration of a patients’ risk for disease and their characteristics,...
Latest News
FDA approves cantharidin for molluscum contagiosum
The development marks the first FDA-approved treatment for the condition.
Article
Screening for hepatitis B: Where the CDC and USPSTF diverge
The CDC recently issued guidance on screening for hepatitis B infection. Here’s a look at how (and why) these recommendations differ from those of...
From the Journals
Asthma severity, exacerbations increase with RV infection
Immunological and quantitative mRNA assays support a pathogenesis role for histamine-releasing factor.
Conference Coverage
Infection-related chronic illness: A new paradigm for research and treatment
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis...
Conference Coverage
Research points toward combination therapy for Lyme and improved diagnostics
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the...
News from the FDA/CDC
Pneumococcal vaccine label adds injection-site risk
Reports of injection-site necrosis emerged after the vaccine had been approved by the FDA and was administered to a large, diverse, real-world...
Feature
Long COVID and vaccines: Separating facts from falsehoods
Discussions of vaccination with patients, including those with long COVID, are often fraught and challenging. “There’s a lot of fear that they...
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.